FARMERS & MERCHANTS BANCORP financials

FMCB CIK 0001085913

Source: EDGAR filings · Built 2026-06-19T00:54:49Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 96.62M 101.34M 88.38M 97.59M 57.89M 50.41M
Net Debt -143.21M -210.26M -407.84M -584.76M 296.18M 497.75M
Return on Equity (ROE) 14.50% 15.44% 16.06% 15.47% 14.32% 13.86%
Return on Assets (ROA) 1.65% 1.65% 1.66% 1.41% 1.28% 1.29%
Debt-to-Equity 0.00× 0.00× 0.01× 0.01× 2.18× 2.08×
Effective Tax Rate 27.31% 27.64% 24.23% 24.71% 24.89% 24.65%
Cash Conversion Ratio 1.11× 1.17× 1.06× 1.36× 0.90× 0.99×
Accruals Ratio -0.00× -0.00× -0.00× -0.01× 0.00× 0.00×
CapEx Coverage 13.75× 43.24× 18.77× 24.29× 28.98× 7.54×
Free Cash Flow Per Share $138.27 $138.64 $116.69 $125.48 $73.32 $63.54

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Income Tax Expense (Benefit) 35.17M 33.79M 28.24M 24.65M 21.98M 19.22M
Net Income (Loss) Attributable to Parent 93.61M 88.46M 88.31M 75.09M 66.34M 58.73M
Earnings Per Share, Basic $134.96 $121.02 $116.61 $96.55 $84.01 $74.03
Weighted Average Number of Shares Outstanding, Basic 693,589 730,914 757,336 777,726 789,646 793,337
Earnings Per Share, Diluted $133.96 $121.02 $116.61 $96.55 $84.01 $74.03
Weighted Average Number of Shares Outstanding, Diluted 698,768 730,914 757,336 777,726 789,646 793,337

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 144.86M 212.56M 410.64M 588.26M 715.46M 383.84M
Assets 5.69B 5.37B 5.31B 5.33B 5.18B 4.55B
Liabilities 5.04B 4.80B 4.76B 4.84B 4.71B 4.13B
Stockholders' Equity Attributable to Parent 645.51M 573.07M 549.75M 485.31M 463.14M 423.67M
Common Stock, Shares, Outstanding 697,904 699,798 747,971 768,337 789,646 789,646

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 104.19M 103.73M 93.35M 101.78M 59.96M 58.12M
Payments to Acquire Property, Plant, and Equipment 7.58M 2.40M 4.97M 4.19M 2.07M 7.71M
Net Cash Provided by (Used in) Investing Activities -402.01M -274.58M -146.55M -315.30M -296.15M -736.75M
Payments for Repurchase of Common Stock 2.93M 45.26M 20.36M 20.31M 0 2.83M
Net Cash Provided by (Used in) Financing Activities 230.12M -27.23M -124.42M 86.32M 567.81M 767.71M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (FMCB CIK 0001085913), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

PTPI

Petros Pharmaceuticals, Inc.

ANGO

AngioDynamics, Inc.

GPCR

Structure Therapeutics Inc.